Please Wait.....
Report
Recombinant DNA Technology Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
Market Report I 2023-11-24 I 149 Pages I IMARC Group
The global recombinant DNA technology market size reached US$ 729.8 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 966.8 Billion by 2028, exhibiting a growth rate (CAGR) of 4.80% during 2022-2028.
The advent of recombinant DNA technology has revolutionized development in biology and offered new opportunities for innovations. Also known as genetic engineering, it is currently widely used to alter genetic material outside an organism and obtain improved and desired characteristics in living organisms. It includes the insertion of DNA fragments from several sources that have a desirable gene sequence through an appropriate vector. Besides this, it assists in the safe, affordable, and sufficient production of vital proteins required for dietary purposes and fighting health problems. As a result, it has multidisciplinary applications and a remarkable potential to improve health and enhance food resources and resistance to divergent adverse environmental effects.
Recombinant DNA Technology Market Trends:
The recombinant DNA technology is utilized for improving different health conditions, mainly by developing new vaccines and pharmaceuticals. This, coupled with the improving treatment strategies on account of the developing diagnostics kits, monitoring devices, and new therapeutic approaches, represents one of the key factors impelling the growth of the market. Moreover, there is a rise in the research conducted on genetically modified organisms (GMO), which include microorganisms that are considered as bio degraders and clean fuel producers. This can be accredited to rapid urbanization, growing global population, reducing arable land, considerable rising food shortage and increasing adoption of GMO crops. Apart from this, as recombinant DNA technology offers several innovation opportunities to develop a vast range of therapeutic products with immediate effect in medical genetics and biomedicine, its application is expanding in various sectors. For instance, the integration of recombinant DNA technology with effective gene therapy for replacing the defective gene with normal ones and the production of antigen-specific antibodies for clinical research, studies, and disease diagnosis, are anticipated to drive the market growth in the upcoming years.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global recombinant DNA technology market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product, component, application and end user.
Breakup by Product:
Medical
Therapeutic Agent
Human Protein
Vaccines
Non-Medical
Biotech Crops
Specialty Chemicals
Others
Breakup by Component:
Expression System
Cloning Vector
Breakup by Application:
Food and Agriculture
Health and Disease
Environment
Others
Breakup by End User:
Biotechnology and Pharmaceutical Companies
Academic and Government Research Institutes
Others
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Amgen Inc, Cibus, F.Hoffmann-La Roche Ltd, GenScript, GlaxoSmithKline plc., Horizon Discovery Group plc, Merck KGaA, New England Biolabs, Novo Nordisk A/S, Pfizer Inc., Sanofi S.A and Syngene International Ltd (Biocon Limited).
Key Questions Answered in This Report:
How has the global recombinant DNA technology market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global recombinant DNA technology market?
What are the key regional markets?
What is the breakup of the market based on the product?
What is the breakup of the market based on the component?
What is the breakup of the market based on the application?
What is the breakup of the market based on the end user?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global recombinant DNA technology market and who are the key players?
What is the degree of competition in the industry?
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Recombinant DNA Technology Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Product
6.1 Medical
6.1.1 Market Trends
6.1.2 Key Segments
6.1.2.1 Therapeutic Agent
6.1.2.2 Human Protein
6.1.2.3 Vaccines
6.1.3 Market Forecast
6.2 Non-Medical
6.2.1 Market Trends
6.2.2 Key Segments
6.2.2.1 Biotech Crops
6.2.2.2 Specialty Chemicals
6.2.2.3 Others
6.2.3 Market Forecast
7 Market Breakup by Component
7.1 Expression System
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Cloning Vector
7.2.1 Market Trends
7.2.2 Market Forecast
8 Market Breakup by Application
8.1 Food and Agriculture
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Health and Disease
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Environment
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Others
8.4.1 Market Trends
8.4.2 Market Forecast
9 Market Breakup by End User
9.1 Biotechnology and Pharmaceutical Companies
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Academic and Government Research Institutes
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Others
9.3.1 Market Trends
9.3.2 Market Forecast
10 Market Breakup by Region
10.1 North America
10.1.1 United States
10.1.1.1 Market Trends
10.1.1.2 Market Forecast
10.1.2 Canada
10.1.2.1 Market Trends
10.1.2.2 Market Forecast
10.2 Asia-Pacific
10.2.1 China
10.2.1.1 Market Trends
10.2.1.2 Market Forecast
10.2.2 Japan
10.2.2.1 Market Trends
10.2.2.2 Market Forecast
10.2.3 India
10.2.3.1 Market Trends
10.2.3.2 Market Forecast
10.2.4 South Korea
10.2.4.1 Market Trends
10.2.4.2 Market Forecast
10.2.5 Australia
10.2.5.1 Market Trends
10.2.5.2 Market Forecast
10.2.6 Indonesia
10.2.6.1 Market Trends
10.2.6.2 Market Forecast
10.2.7 Others
10.2.7.1 Market Trends
10.2.7.2 Market Forecast
10.3 Europe
10.3.1 Germany
10.3.1.1 Market Trends
10.3.1.2 Market Forecast
10.3.2 France
10.3.2.1 Market Trends
10.3.2.2 Market Forecast
10.3.3 United Kingdom
10.3.3.1 Market Trends
10.3.3.2 Market Forecast
10.3.4 Italy
10.3.4.1 Market Trends
10.3.4.2 Market Forecast
10.3.5 Spain
10.3.5.1 Market Trends
10.3.5.2 Market Forecast
10.3.6 Russia
10.3.6.1 Market Trends
10.3.6.2 Market Forecast
10.3.7 Others
10.3.7.1 Market Trends
10.3.7.2 Market Forecast
10.4 Latin America
10.4.1 Brazil
10.4.1.1 Market Trends
10.4.1.2 Market Forecast
10.4.2 Mexico
10.4.2.1 Market Trends
10.4.2.2 Market Forecast
10.4.3 Others
10.4.3.1 Market Trends
10.4.3.2 Market Forecast
10.5 Middle East and Africa
10.5.1 Market Trends
10.5.2 Market Breakup by Country
10.5.3 Market Forecast
11 SWOT Analysis
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 Price Analysis
15 Competitive Landscape
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 Amgen Inc
15.3.1.1 Company Overview
15.3.1.2 Product Portfolio
15.3.1.3 Financials
15.3.1.4 SWOT Analysis
15.3.2 Cibus
15.3.2.1 Company Overview
15.3.2.2 Product Portfolio
15.3.3 F.Hoffmann-La Roche Ltd
15.3.3.1 Company Overview
15.3.3.2 Product Portfolio
15.3.3.3 SWOT Analysis
15.3.4 GenScript
15.3.4.1 Company Overview
15.3.4.2 Product Portfolio
15.3.5 GlaxoSmithKline plc.
15.3.5.1 Company Overview
15.3.5.2 Product Portfolio
15.3.5.3 Financials
15.3.5.4 SWOT Analysis
15.3.6 Horizon Discovery Group plc
15.3.6.1 Company Overview
15.3.6.2 Product Portfolio
15.3.7 Merck KGaA
15.3.7.1 Company Overview
15.3.7.2 Product Portfolio
15.3.7.3 Financials
15.3.7.4 SWOT Analysis
15.3.8 New England Biolabs
15.3.8.1 Company Overview
15.3.8.2 Product Portfolio
15.3.9 Novo Nordisk A/S
15.3.9.1 Company Overview
15.3.9.2 Product Portfolio
15.3.9.3 Financials
15.3.9.4 SWOT Analysis
15.3.10 Pfizer Inc.
15.3.10.1 Company Overview
15.3.10.2 Product Portfolio
15.3.10.3 Financials
15.3.10.4 SWOT Analysis
15.3.11 Sanofi S.A
15.3.11.1 Company Overview
15.3.11.2 Product Portfolio
15.3.11.3 Financials
15.3.11.4 SWOT Analysis
15.3.12 Syngene International Ltd (Biocon Limited)
15.3.12.1 Company Overview
15.3.12.2 Product Portfolio
15.3.12.3 Financials
15.3.12.4 SWOT Analysis
Figure 1: Global: Recombinant DNA Technology Market: Major Drivers and Challenges
Figure 2: Global: Recombinant DNA Technology Market: Sales Value (in Billion US$), 2017-2022
Figure 3: Global: Recombinant DNA Technology Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 4: Global: Recombinant DNA Technology Market: Breakup by Product (in %), 2022
Figure 5: Global: Recombinant DNA Technology Market: Breakup by Component (in %), 2022
Figure 6: Global: Recombinant DNA Technology Market: Breakup by Application (in %), 2022
Figure 7: Global: Recombinant DNA Technology Market: Breakup by End User (in %), 2022
Figure 8: Global: Recombinant DNA Technology Market: Breakup by Region (in %), 2022
Figure 9: Global: Recombinant DNA Technology (Medical) Market: Sales Value (in Million US$), 2017 & 2022
Figure 10: Global: Recombinant DNA Technology (Medical) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 11: Global: Recombinant DNA Technology (Non-Medical) Market: Sales Value (in Million US$), 2017 & 2022
Figure 12: Global: Recombinant DNA Technology (Non-Medical) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 13: Global: Recombinant DNA Technology (Expression System) Market: Sales Value (in Million US$), 2017 & 2022
Figure 14: Global: Recombinant DNA Technology (Expression System) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 15: Global: Recombinant DNA Technology (Cloning Vector) Market: Sales Value (in Million US$), 2017 & 2022
Figure 16: Global: Recombinant DNA Technology (Cloning Vector) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 17: Global: Recombinant DNA Technology (Food and Agriculture) Market: Sales Value (in Million US$), 2017 & 2022
Figure 18: Global: Recombinant DNA Technology (Food and Agriculture) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 19: Global: Recombinant DNA Technology (Health and Disease) Market: Sales Value (in Million US$), 2017 & 2022
Figure 20: Global: Recombinant DNA Technology (Health and Disease) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 21: Global: Recombinant DNA Technology (Environment) Market: Sales Value (in Million US$), 2017 & 2022
Figure 22: Global: Recombinant DNA Technology (Environment) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 23: Global: Recombinant DNA Technology (Other Applications) Market: Sales Value (in Million US$), 2017 & 2022
Figure 24: Global: Recombinant DNA Technology (Other Applications) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 25: Global: Recombinant DNA Technology (Biotechnology and Pharmaceutical Companies) Market: Sales Value (in Million US$), 2017 & 2022
Figure 26: Global: Recombinant DNA Technology (Biotechnology and Pharmaceutical Companies) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 27: Global: Recombinant DNA Technology (Academic and Government Research Institutes) Market: Sales Value (in Million US$), 2017 & 2022
Figure 28: Global: Recombinant DNA Technology (Academic and Government Research Institutes) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 29: Global: Recombinant DNA Technology (Other End Users) Market: Sales Value (in Million US$), 2017 & 2022
Figure 30: Global: Recombinant DNA Technology (Other End Users) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 31: North America: Recombinant DNA Technology Market: Sales Value (in Million US$), 2017 & 2022
Figure 32: North America: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 33: United States: Recombinant DNA Technology Market: Sales Value (in Million US$), 2017 & 2022
Figure 34: United States: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 35: Canada: Recombinant DNA Technology Market: Sales Value (in Million US$), 2017 & 2022
Figure 36: Canada: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 37: Asia-Pacific: Recombinant DNA Technology Market: Sales Value (in Million US$), 2017 & 2022
Figure 38: Asia-Pacific: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 39: China: Recombinant DNA Technology Market: Sales Value (in Million US$), 2017 & 2022
Figure 40: China: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 41: Japan: Recombinant DNA Technology Market: Sales Value (in Million US$), 2017 & 2022
Figure 42: Japan: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 43: India: Recombinant DNA Technology Market: Sales Value (in Million US$), 2017 & 2022
Figure 44: India: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 45: South Korea: Recombinant DNA Technology Market: Sales Value (in Million US$), 2017 & 2022
Figure 46: South Korea: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 47: Australia: Recombinant DNA Technology Market: Sales Value (in Million US$), 2017 & 2022
Figure 48: Australia: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 49: Indonesia: Recombinant DNA Technology Market: Sales Value (in Million US$), 2017 & 2022
Figure 50: Indonesia: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 51: Others: Recombinant DNA Technology Market: Sales Value (in Million US$), 2017 & 2022
Figure 52: Others: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 53: Europe: Recombinant DNA Technology Market: Sales Value (in Million US$), 2017 & 2022
Figure 54: Europe: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 55: Germany: Recombinant DNA Technology Market: Sales Value (in Million US$), 2017 & 2022
Figure 56: Germany: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 57: France: Recombinant DNA Technology Market: Sales Value (in Million US$), 2017 & 2022
Figure 58: France: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 59: United Kingdom: Recombinant DNA Technology Market: Sales Value (in Million US$), 2017 & 2022
Figure 60: United Kingdom: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 61: Italy: Recombinant DNA Technology Market: Sales Value (in Million US$), 2017 & 2022
Figure 62: Italy: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 63: Spain: Recombinant DNA Technology Market: Sales Value (in Million US$), 2017 & 2022
Figure 64: Spain: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 65: Russia: Recombinant DNA Technology Market: Sales Value (in Million US$), 2017 & 2022
Figure 66: Russia: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 67: Others: Recombinant DNA Technology Market: Sales Value (in Million US$), 2017 & 2022
Figure 68: Others: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 69: Latin America: Recombinant DNA Technology Market: Sales Value (in Million US$), 2017 & 2022
Figure 70: Latin America: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 71: Brazil: Recombinant DNA Technology Market: Sales Value (in Million US$), 2017 & 2022
Figure 72: Brazil: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 73: Mexico: Recombinant DNA Technology Market: Sales Value (in Million US$), 2017 & 2022
Figure 74: Mexico: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 75: Others: Recombinant DNA Technology Market: Sales Value (in Million US$), 2017 & 2022
Figure 76: Others: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 77: Middle East and Africa: Recombinant DNA Technology Market: Sales Value (in Million US$), 2017 & 2022
Figure 78: Middle East and Africa: Recombinant DNA Technology Market: Breakup by Country (in %), 2022
Figure 79: Middle East and Africa: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 80: Global: Recombinant DNA Technology Industry: SWOT Analysis
Figure 81: Global: Recombinant DNA Technology Industry: Value Chain Analysis
Figure 82: Global: Recombinant DNA Technology Industry: Porter's Five Forces Analysis
Table 1: Global: Recombinant DNA Technology Market: Key Industry Highlights, 2022 and 2028
Table 2: Global: Recombinant DNA Technology Market Forecast: Breakup by Product (in Million US$), 2023-2028
Table 3: Global: Recombinant DNA Technology Market Forecast: Breakup by Component (in Million US$), 2023-2028
Table 4: Global: Recombinant DNA Technology Market Forecast: Breakup by Application (in Million US$), 2023-2028
Table 5: Global: Recombinant DNA Technology Market Forecast: Breakup by End User (in Million US$), 2023-2028
Table 6: Global: Recombinant DNA Technology Market Forecast: Breakup by Region (in Million US$), 2023-2028
Table 7: Global: Recombinant DNA Technology Market: Competitive Structure
Table 8: Global: Recombinant DNA Technology Market: Key Players
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security